Analysts Point To Neurocrine Biosciences, Inc (NASDAQ: NBIX) Growth In The Future

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.

Stocks Info

As a NASDAQ listed company, NBIX falls under the Healthcare sector while operating within the Drug Manufacturers – Specialty & Generic industry segment. The current market capitalization of Neurocrine Biosciences, Inc is $11.28B. A total of 0.8 million shares were traded on the day, compared to an average of 1.29M shares.

In the most recent transaction, Cooke Julie sold 1,551 shares of NBIX for 116.78 per share on Feb 13 ’25. After the transaction, the Chief Human Resources Officer now owns 19,544 company shares. In a previous transaction on Feb 13 ’25, GORMAN KEVIN CHARLES sold 5,844 shares at 116.69 per share. NBIX shares that Director owns now total 521,618.

Among the insiders who sold shares, SHERWIN STEPHEN A disposed of 13,831 shares on Feb 13 ’25 at a per-share price of $116.69. This resulted in the Director holding 10,673 shares of NBIX after the transaction. In another insider transaction, ROBERTS EIRY sold 1,718 shares at $116.85 per share on Feb 13 ’25. Company shares held by the Chief Medical Officer now total 34,252.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, NBIX has a high of $157.98 and a low of $105.18.

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. NBIX’s latest balance sheet shows that the firm has $711.30M in Cash & Short Term Investments as of fiscal 2021. There were $440.40M in debt and $245.80M in liabilities at the time. Its Book Value Per Share was $26.05, while its Total Shareholder’s Equity was $1.37B.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NBIX is Buy with a score of 4.62.

Most Popular

Related Posts